We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$2.09B
AUM Growth
-$289M
Cap. Flow
-$380M
Cap. Flow %
-18.22%
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$11.6M
2
PSX icon
Phillips 66
PSX
+$11.1M
3
MET icon
MetLife
MET
+$10.1M
4
M icon
Macy's
M
+$9.08M
5
ORLY icon
O'Reilly Automotive
ORLY
+$8.37M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10.7M
3
GAP
The Gap Inc
GAP
+$8.4M
4
UAL icon
United Airlines
UAL
+$8.14M
5
SKX
Skechers
SKX
+$7.54M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.17%
2 Industrials 14.75%
3 Technology 13.58%
4 Healthcare 12.19%
5 Financials 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCI icon
401
HCI Group
HCI
$2.23B
$1.12M 0.05%
27,487
-3,035
-10% -$117K
OKSB
402
DELISTED
Southwest Bancorp Inc/OK
OKSB
$1.11M 0.05%
+65,170
New +$1.11M
CPA icon
403
Copa Holdings
CPA
$5.76B
$1.11M 0.05%
7,767
-188
-2% -$26.3K
AVY icon
404
Avery Dennison
AVY
$13B
$1.1M 0.05%
21,570
-2,277
-10% -$113K
MWV
405
DELISTED
MEADWESTVACO CORP
MWV
$1.1M 0.05%
24,906
-17,426
-41% -$707K
ARC
406
DELISTED
ARC Document Solutions, Inc.
ARC
$1.1M 0.05%
187,087
+22,860
+14% +$145K
GME icon
407
GameStop
GME
$9.75B
$1.09M 0.05%
108,048
-5,548
-5% -$54.3K
MBUU icon
408
Malibu Boats
MBUU
$541M
$1.09M 0.05%
+54,360
New +$1.12M
LAZ icon
409
Lazard
LAZ
$4.13B
$1.09M 0.05%
21,174
-2,401
-10% -$118K
PFBC icon
410
Preferred Bank
PFBC
$1.24B
$1.09M 0.05%
45,937
-5,060
-10% -$118K
SAMG icon
411
Silvercrest Asset Management
SAMG
$79M
$1.08M 0.05%
63,025
+5,484
+10% +$95.7K
SCMP
412
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$1.08M 0.05%
156,842
-17,303
-10% -$122K
ACIC icon
413
American Coastal Insurance
ACIC
$515M
$1.07M 0.05%
62,016
-38,514
-38% -$628K
EV
414
DELISTED
Eaton Vance Corp.
EV
$1.06M 0.05%
28,110
-1,397
-5% -$51.6K
DVAX
415
DELISTED
Dynavax Technologies
DVAX
$1.06M 0.05%
66,314
-7,285
-10% -$110K
HBIO icon
416
Harvard Bioscience
HBIO
$27.5M
$1.06M 0.05%
23,318
-2,574
-10% -$108K
PMD
417
DELISTED
Psychemedics Corporation
PMD
$1.05M 0.05%
74,517
-8,198
-10% -$125K
FTR
418
DELISTED
Frontier Communications Corp.
FTR
$1.05M 0.05%
12,044
-3,832
-24% -$331K
SLP icon
419
Simulations Plus
SLP
$369M
$1.04M 0.05%
184,262
+2,494
+1% +$15K
SNAK
420
DELISTED
Inventure Foods, Inc.
SNAK
$1.03M 0.05%
91,845
-10,103
-10% -$128K
VIPS icon
421
Vipshop
VIPS
$7.37B
$1.02M 0.05%
54,100
+24,700
+84% +$396K
SGC icon
422
Superior Group of Companies
SGC
$185M
$1M 0.05%
123,478
-13,586
-10% -$110K
AVTA
423
DELISTED
Avantax, Inc. Common Stock
AVTA
$991K 0.05%
52,495
-5,797
-10% -$109K
WIN
424
DELISTED
Windstream Holdings Inc
WIN
$990K 0.05%
12,695
-5,415
-30% -$395K
PBCT
425
DELISTED
People's United Financial Inc
PBCT
$974K 0.05%
64,225
-9,744
-13% -$142K

Similar funds

Cadence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.

  • Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
  • Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
  • Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
  • Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
  • Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
  • Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
  • Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.